Governance Report of the Directors between the Company, Frostrow, the Depositary and the continuation of the Company at the 2019 Annual General Prime Broker the Delegation Agreement.
Meeting and every five years thereafter.
The Delegation Agreement transfers the Depositarys liability Results and dividends for the loss of the Companys financial instruments held in The results attributable to shareholders for the year and the custody by the Prime Broker to the Prime Broker in transfer from reserves are shown on pages 52 to 54.
Details accordance with the AIFMD.
The Company has consented to of the Companys dividend record can be found on page 3. the transfer and reuse of its assets by the Prime Broker known as rehypothecation in accordance with the terms of Beneficial owners of shares information an institutional account agreement between the Company, rights the Prime Broker and certain other J. P. Morgan entities as Beneficial owners of shares who have been nominated by defined therein.
See page 23 for further details.
the registered holder of those shares to receive information rights under section 146 of the Companies Act 2006 are Prime brokerage agreement required to direct all communications to the registered The Company appointed J. P. Morgan Securities LLC the holder of their shares rather than to the Companys Prime Broker on the terms and subject to the conditions registrar, Capita Asset Services, or to the Company directly.
of the prime brokerage agreement between the Company, Frostrow and the Depositary the Prime Brokerage Directors & officers liability insurance cover Agreement.
The Prime Broker receives interest on the Directors & officers liability insurance cover was drawn overdraft as detailed in note 12 on page 63. maintained by the Company during the year ended 31 March The Prime Broker is a registered broker-dealer and is regulated 2017.
It is intended that this policy will continue for the year ending 31 March 2018 and subsequent years.
by the United States Securities and Exchange Commission.
Continuation of the Company In accordance with the Companys Articles of Association, shareholders will have an opportunity to vote on the Substantial interests in share capital The Company was aware of the following substantial interests in the voting rights of the Company as at 31 May 2017, the latest practicable date before publication of the Annual Report: 31 May 2017 31 March 2017 Number of % of issued Number of % of issued Shareholder shares share capital shares share capital Investec Wealth & Investment Limited 5,783,166 12.4 5,739,451 12.3 Rathbone Brothers plc 2,737,184 5.9 2,674,758 5.8 Alliance Trust Savings Limited 2,661,418 5.7 2,594,162 5.6 Speirs & Jeffrey Limited 2,057,778 4.4 2,058,128 4.4 Quilter Cheviot Investment Management 2,018,197 4.3 2,033,683 4.4 Hargreaves Lansdown plc 1,956,601 4.2 1,925,929 4.1 Charles Stanley & Co Limited 1,949,166 4.2 1,943,410 4.2 Brewin Dolphin Limited 1,572,291 3.4 1,471,151 3.2 As at 31 March 2017 the Company had 46,506,278 shares in issue.
As at 31 May 2017 there were 46,516,278 shares in issue.
Worldwide Healthcare Trust PLC Annual Report for the year ended 31 March 2017 29
